Concepedia

Lillian Sun

LS

6

Publications

582

Citations

6

H-Index

2017

Active since

Affiliations

National Cancer Institute(Current)

National Institute on Deafness and Other Communication Disorders

Johns Hopkins University

Johns Hopkins Medicine

National Institutes of Health

Lillian Sun is an author at National Cancer Institute specializing in t cell immunity, immunomodulation, and tumor biology.

ORCID

Top concepts

Publications per year

2017–2019

6

Publications

6

Inhibiting myeloid-derived suppressor cell trafficking enhances T cell immunotherapy

Lillian Sun, Paúl E. Clavijo, Yvette Robbins et al. · JCI Insight · 2019 · 228 citations · Full text

, , +18

PD-1 blockade reverses adaptive immune resistance induced by high-dose hypofractionated but not low-dose daily fractionated radiation

Megan V. Morisada, Paúl E. Clavijo, Ellen Moore et al. · OncoImmunology · 2017 · 143 citations · Full text

Neoadjuvant PD-1 Immune Checkpoint Blockade Reverses Functional Immunodominance among Tumor Antigen–Specific T Cells

Jay Friedman, Ellen Moore, Paul Zolkind et al. · Clinical Cancer Research · 2019 · 78 citations · Full text

WEE1 kinase inhibition reverses G2/M cell cycle checkpoint activation to sensitize cancer cells to immunotherapy

Lillian Sun, Ellen Moore, Rose Berman et al. · OncoImmunology · 2018 · 56 citations · Full text

Inhibition of WEE1 kinase and cell cycle checkpoint activation sensitizes head and neck cancers to natural killer cell therapies

Jay Friedman, Megan V. Morisada, Lillian Sun et al. · Journal for ImmunoTherapy of Cancer · 2018 · 49 citations · Full text

Rows per page

1–5 of 6